Results 281 to 290 of about 611,597 (310)

Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease

New England Journal of Medicine
Xenotransplantation offers a potential solution to the organ shortage crisis. A 62-year-old hemodialysis-dependent man with long-standing diabetes, advanced vasculopathy, and marked dialysis-access challenges received a gene-edited porcine kidney with 69 genomic edits, including deletion of three glycan antigens, inactivation of porcine endogenous ...
Tatsuo Kawai, Winfred W. Williams, Nahel Elias, Jay A. Fishman, Kerry Crisalli, Alban Longchamp, Ivy A. Rosales, Michael Duggan, Shoko Kimura, Leela Morena, Thiago J. Borges, Toshihide Tomosugi, Ahmad Karadagi, Tsukasa Nakamura, Kassem Safa, Alessia Giarraputo, Claire T. Avillach, Eva D. Patalas, R. Neal Smith, David H. Sachs, A. Benedict Cosimi, Joren C. Madsen, David K.C. Cooper, Richard Pierson, Steve Perrin, Ranjith P. Anand, Sagar Chhangawala, Matthew Coscarella, Alexandre Daigneault, Feng Li, Owen Pearce, Wenning Qin, William T. Serkin, Vincent Yeung, Kristen Getchell, Susan C. Low, Michael Curtis, Robert B. Colvin, Leonardo V. Riella   +38 more
openaire   +2 more sources

Onconephrology: The intersections between the kidney and cancer

Ca-A Cancer Journal for Clinicians, 2021
Mitchell H Rosner, Kenar D Jhaveri, Blaithin A Mcmahon   +2 more
exaly  

End Stage Kidney Disease Treatment Options.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association
As patients progress through chronic kidney disease, they are eventually faced with the reality of having to choose which type of treatment they want when their kidneys are no longer functioning enough to sustain them - when they have reached end stage kidney disease.
Rachael, Buening, Sheila, Deziel
openaire   +1 more source

End-stage kidney disease

2012
Edwina A. Brown, Fliss E. M. Murtagh, Emma Murphy   +2 more
openaire   +1 more source

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao, Xuesong Han, Leticia Nogueira   +2 more
exaly  

Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world

Kidney International Supplements, 2020
Barnaby Hole, Mark A Brown, Cécile Couchoud   +2 more
exaly  

Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes

Kidney International Supplements, 2020
Roberto Flavio Pecoits-Filho, Ikechi G Okpechi, Jo-Ann Donner   +2 more
exaly  

Considerations on equity in management of end-stage kidney disease in low- and middle-income countries

Kidney International Supplements, 2020
Wim Van Biesen, Vivekanand Jha, Ali K Abu-Alfa   +2 more
exaly  

Developing the ethical framework of end-stage kidney disease care: from practice to policy

Kidney International Supplements, 2020
Valerie A Luyckx, Dominique E Martin, Aminu K Bello   +2 more
exaly  

Worldwide access to treatment for end-stage kidney disease: a systematic review

Lancet, The, 2015
Toshiharu Ninomiya, Vivekanand Jha, Bruce Neal   +2 more
exaly